The University of Southampton
University of Southampton Institutional Repository

Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)

Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)

This article is a report of the fourth meeting of the Harmonising Outcome Measures for Eczema (HOME) initiative held in Malmö, Sweden on 23-24 April 2015 (HOME IV). The aim of the meeting was to achieve consensus over the preferred outcome instruments for measuring patient-reported symptoms and quality of life for the HOME core outcome set for atopic eczema (AE). Following presentations, which included data from systematic reviews, consensus discussions were held in a mixture of whole group and small group discussions. Small groups were allocated a priori to ensure representation of different stakeholders and countries. Decisions were voted on using electronic keypads. For the patient-reported symptoms, the group agreed by vote that itch, sleep loss, dryness, redness/inflamed skin and irritated skin were all considered essential aspects of AE symptoms. Many instruments for capturing patient-reported symptoms were discussed [including the Patient-Oriented SCOring Atopic Dermatitis index, Patient-Oriented Eczema Measure (POEM), Self-Administered Eczema Area and Severity Index, Itch Severity Scale, Atopic Dermatitis Quickscore and the Nottingham Eczema Severity Score] and, by consensus, POEM was selected as the preferred instrument to measure patient-reported symptoms. Further work is needed to determine the reliability and measurement error of POEM. Further work is also required to establish the importance of pain/soreness and the importance of collecting information regarding the intensity of symptoms in addition to their frequency. Much of the discussion on quality of life concerned the Dermatology Life Quality Index and Quality of Life Index for Atopic Dermatitis; however, consensus on a preferred instrument for measuring this domain could not be reached. In summary, POEM is recommended as the HOME core outcome instrument for measuring AE symptoms.

Checklist, Clinical Trials as Topic, Dermatitis, Atopic/therapy, Dermatologic Agents/therapeutic use, Global Health, Humans, Long-Term Care, Patient Reported Outcome Measures, Quality of Life, Review Literature as Topic, Treatment Outcome
0007-0963
69-79
Chalmers, J.R.
94e08e98-5c93-405d-9278-97acfe4985a0
Simpson, E.
127514a1-9431-48d2-b3dc-ff871a5e4155
Apfelbacher, C.J.
cf3552c6-92ea-4f3d-8150-9f19c922f590
Thomas, K.S.
cd26bdad-69c4-434a-9ccb-d3efa945a3d3
von Kobyletzki, L.
8fbbf78b-e2e2-4ad7-ad3f-29d313521873
Schmitt, J.
ec95552c-6f07-4549-8582-86933b3c6599
Singh, J.A.
26e60da2-de4c-44d1-9020-b55aeaefa91e
Svensson, Å.
703d7057-ebf6-4002-85b9-dd6392a3c59d
Williams, H.C.
feacc6df-79cb-41cf-a947-9d5cce22011c
Abuabara, K.
10a2192f-d7fb-4ef8-90d4-b58cc0aa9c7c
Aoki, V.
cc60023d-d343-4c9d-9dab-ff8a8806ada8
Ardeleanu, M.
ee060a44-0227-47bb-9a8e-adfe4a8cc477
Awici-Rasmussen, M.
0114cfb9-57ee-4150-84c0-888cc06cd6eb
Barbarot, S.
6ddfb8ad-9f41-4ba5-a1af-ff247981f4f2
Berents, T.L.
4d5592ee-c8f5-4034-b765-0391bbef5eb4
Block, J.
df6c154d-7166-4a39-beb3-a962249a75c6
Bragg, A.
0083c184-46ec-403b-995f-7054671828e3
Burton, T.
84cc8f88-8b62-4223-8050-bdfc65611d5e
Bjerring Clemmensen, K.K.
889992b5-7751-4433-8f5c-8714f16a2463
Creswell-Melville, A.
2c9daeb7-94c0-4db9-adf2-a0bf69d36c6e
Dinesen, M.
5ec171a1-2404-4a3d-bf43-cb46ddc2a97d
Drucker, A.
1c94c0a7-c14b-44c2-a1d6-62f6a0ee0e0c
Eckert, L.
b2f0cad4-7e41-4327-9514-bf6ca59a9b39
Flohr, C.
2cd7a518-1a24-4fc7-b099-2a032fdf2068
Garg, M.
be328e0d-f0d6-4059-a5bd-d1a7e62e0867
Gerbens, L.A.A.
e6800106-6232-44f1-ab9d-b1e7e6ad66d9
Graff, A.L.B.
8b883bef-52af-46e4-b46f-3db1108af7ff
Hanifin, J.
a9c2b138-4c0d-4aa0-b966-99a4b8cc51d4
Heinl, D.
29c88699-32d3-4045-8000-ae3652c0c8fa
Humphreys, R.
ba7acc08-ed16-4315-ac5b-31c67e3d0e5c
Ishii, H.A.
9f815fe9-a09e-4ab9-a74b-b965fe85ed83
Kataoka, Y.
0d8cb2b8-0dea-45e5-9b2f-e813bfc1a41c
Leshem, Y.A.
2b93efc1-acd0-4275-835c-7e42eb90a4c7
Marquort, B.
d0a1010a-4bb6-4735-baac-78dbf11da3d5
Massuel, M.-A.
9bdfae78-75a2-4ba6-9bb0-ec44b4fa9eca
Merhand, S.
72db0d60-48bd-482b-8893-5eb4437c9c64
Mizutani, H.
654eb32d-b191-43ac-9e43-92e6e1b9948e
Murota, H.
0bdbddc6-c373-42fb-9c35-911f7979e477
Murrell, D.F.
62da494e-e6f0-4abd-893a-538ba3e612b8
Nakahara, T.
f19d5235-0589-4f90-bca0-59dd486a5679
Nasr, I.
dbb9b1b2-ba7c-417d-b048-1d16b1a09a85
Nograles, K.
e6d7c193-0214-42a8-a73f-548f5603f509
Ohya, Y.
4ad7d24a-4ae4-4320-a658-56d645b8365d
Osterloh, I.
6df28def-5263-46cf-8f20-528f950bb8f0
Pander, J.
4241f3f3-af6b-4105-a213-7f84cd1ab57c
Prinsen, C.
f30459a0-1a60-42f8-98e9-b782c3fbce15
Purkins, L.
67c5d676-11f7-46ec-af95-9fdf5a8aa308
Ridd, M.
2f15120c-d5fa-4f5d-bb86-21356e034df7
Sach, T.
5c09256f-ebed-4d14-853a-181f6c92d6f2
Zhao, C.Y.
b09dbfd0-1e25-4821-a713-842c64fff508
on behalf of the long-term control of eczema working group for the HOME initiative
Chalmers, J.R.
94e08e98-5c93-405d-9278-97acfe4985a0
Simpson, E.
127514a1-9431-48d2-b3dc-ff871a5e4155
Apfelbacher, C.J.
cf3552c6-92ea-4f3d-8150-9f19c922f590
Thomas, K.S.
cd26bdad-69c4-434a-9ccb-d3efa945a3d3
von Kobyletzki, L.
8fbbf78b-e2e2-4ad7-ad3f-29d313521873
Schmitt, J.
ec95552c-6f07-4549-8582-86933b3c6599
Singh, J.A.
26e60da2-de4c-44d1-9020-b55aeaefa91e
Svensson, Å.
703d7057-ebf6-4002-85b9-dd6392a3c59d
Williams, H.C.
feacc6df-79cb-41cf-a947-9d5cce22011c
Abuabara, K.
10a2192f-d7fb-4ef8-90d4-b58cc0aa9c7c
Aoki, V.
cc60023d-d343-4c9d-9dab-ff8a8806ada8
Ardeleanu, M.
ee060a44-0227-47bb-9a8e-adfe4a8cc477
Awici-Rasmussen, M.
0114cfb9-57ee-4150-84c0-888cc06cd6eb
Barbarot, S.
6ddfb8ad-9f41-4ba5-a1af-ff247981f4f2
Berents, T.L.
4d5592ee-c8f5-4034-b765-0391bbef5eb4
Block, J.
df6c154d-7166-4a39-beb3-a962249a75c6
Bragg, A.
0083c184-46ec-403b-995f-7054671828e3
Burton, T.
84cc8f88-8b62-4223-8050-bdfc65611d5e
Bjerring Clemmensen, K.K.
889992b5-7751-4433-8f5c-8714f16a2463
Creswell-Melville, A.
2c9daeb7-94c0-4db9-adf2-a0bf69d36c6e
Dinesen, M.
5ec171a1-2404-4a3d-bf43-cb46ddc2a97d
Drucker, A.
1c94c0a7-c14b-44c2-a1d6-62f6a0ee0e0c
Eckert, L.
b2f0cad4-7e41-4327-9514-bf6ca59a9b39
Flohr, C.
2cd7a518-1a24-4fc7-b099-2a032fdf2068
Garg, M.
be328e0d-f0d6-4059-a5bd-d1a7e62e0867
Gerbens, L.A.A.
e6800106-6232-44f1-ab9d-b1e7e6ad66d9
Graff, A.L.B.
8b883bef-52af-46e4-b46f-3db1108af7ff
Hanifin, J.
a9c2b138-4c0d-4aa0-b966-99a4b8cc51d4
Heinl, D.
29c88699-32d3-4045-8000-ae3652c0c8fa
Humphreys, R.
ba7acc08-ed16-4315-ac5b-31c67e3d0e5c
Ishii, H.A.
9f815fe9-a09e-4ab9-a74b-b965fe85ed83
Kataoka, Y.
0d8cb2b8-0dea-45e5-9b2f-e813bfc1a41c
Leshem, Y.A.
2b93efc1-acd0-4275-835c-7e42eb90a4c7
Marquort, B.
d0a1010a-4bb6-4735-baac-78dbf11da3d5
Massuel, M.-A.
9bdfae78-75a2-4ba6-9bb0-ec44b4fa9eca
Merhand, S.
72db0d60-48bd-482b-8893-5eb4437c9c64
Mizutani, H.
654eb32d-b191-43ac-9e43-92e6e1b9948e
Murota, H.
0bdbddc6-c373-42fb-9c35-911f7979e477
Murrell, D.F.
62da494e-e6f0-4abd-893a-538ba3e612b8
Nakahara, T.
f19d5235-0589-4f90-bca0-59dd486a5679
Nasr, I.
dbb9b1b2-ba7c-417d-b048-1d16b1a09a85
Nograles, K.
e6d7c193-0214-42a8-a73f-548f5603f509
Ohya, Y.
4ad7d24a-4ae4-4320-a658-56d645b8365d
Osterloh, I.
6df28def-5263-46cf-8f20-528f950bb8f0
Pander, J.
4241f3f3-af6b-4105-a213-7f84cd1ab57c
Prinsen, C.
f30459a0-1a60-42f8-98e9-b782c3fbce15
Purkins, L.
67c5d676-11f7-46ec-af95-9fdf5a8aa308
Ridd, M.
2f15120c-d5fa-4f5d-bb86-21356e034df7
Sach, T.
5c09256f-ebed-4d14-853a-181f6c92d6f2
Zhao, C.Y.
b09dbfd0-1e25-4821-a713-842c64fff508

Chalmers, J.R., Simpson, E. and Apfelbacher, C.J. , on behalf of the long-term control of eczema working group for the HOME initiative (2016) Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). British Journal of Dermatology, 175 (1), 69-79. (doi:10.1111/bjd.14773).

Record type: Article

Abstract

This article is a report of the fourth meeting of the Harmonising Outcome Measures for Eczema (HOME) initiative held in Malmö, Sweden on 23-24 April 2015 (HOME IV). The aim of the meeting was to achieve consensus over the preferred outcome instruments for measuring patient-reported symptoms and quality of life for the HOME core outcome set for atopic eczema (AE). Following presentations, which included data from systematic reviews, consensus discussions were held in a mixture of whole group and small group discussions. Small groups were allocated a priori to ensure representation of different stakeholders and countries. Decisions were voted on using electronic keypads. For the patient-reported symptoms, the group agreed by vote that itch, sleep loss, dryness, redness/inflamed skin and irritated skin were all considered essential aspects of AE symptoms. Many instruments for capturing patient-reported symptoms were discussed [including the Patient-Oriented SCOring Atopic Dermatitis index, Patient-Oriented Eczema Measure (POEM), Self-Administered Eczema Area and Severity Index, Itch Severity Scale, Atopic Dermatitis Quickscore and the Nottingham Eczema Severity Score] and, by consensus, POEM was selected as the preferred instrument to measure patient-reported symptoms. Further work is needed to determine the reliability and measurement error of POEM. Further work is also required to establish the importance of pain/soreness and the importance of collecting information regarding the intensity of symptoms in addition to their frequency. Much of the discussion on quality of life concerned the Dermatology Life Quality Index and Quality of Life Index for Atopic Dermatitis; however, consensus on a preferred instrument for measuring this domain could not be reached. In summary, POEM is recommended as the HOME core outcome instrument for measuring AE symptoms.

Text
bjd0069 - Version of Record
Download (978kB)

More information

Published date: 1 July 2016
Keywords: Checklist, Clinical Trials as Topic, Dermatitis, Atopic/therapy, Dermatologic Agents/therapeutic use, Global Health, Humans, Long-Term Care, Patient Reported Outcome Measures, Quality of Life, Review Literature as Topic, Treatment Outcome

Identifiers

Local EPrints ID: 480854
URI: http://eprints.soton.ac.uk/id/eprint/480854
ISSN: 0007-0963
PURE UUID: fbd5f26b-5353-43bc-a4b2-7624bf5930e6
ORCID for T. Sach: ORCID iD orcid.org/0000-0002-8098-9220

Catalogue record

Date deposited: 10 Aug 2023 16:39
Last modified: 17 Mar 2024 04:20

Export record

Altmetrics

Contributors

Author: J.R. Chalmers
Author: E. Simpson
Author: C.J. Apfelbacher
Author: K.S. Thomas
Author: L. von Kobyletzki
Author: J. Schmitt
Author: J.A. Singh
Author: Å. Svensson
Author: H.C. Williams
Author: K. Abuabara
Author: V. Aoki
Author: M. Ardeleanu
Author: M. Awici-Rasmussen
Author: S. Barbarot
Author: T.L. Berents
Author: J. Block
Author: A. Bragg
Author: T. Burton
Author: K.K. Bjerring Clemmensen
Author: A. Creswell-Melville
Author: M. Dinesen
Author: A. Drucker
Author: L. Eckert
Author: C. Flohr
Author: M. Garg
Author: L.A.A. Gerbens
Author: A.L.B. Graff
Author: J. Hanifin
Author: D. Heinl
Author: R. Humphreys
Author: H.A. Ishii
Author: Y. Kataoka
Author: Y.A. Leshem
Author: B. Marquort
Author: M.-A. Massuel
Author: S. Merhand
Author: H. Mizutani
Author: H. Murota
Author: D.F. Murrell
Author: T. Nakahara
Author: I. Nasr
Author: K. Nograles
Author: Y. Ohya
Author: I. Osterloh
Author: J. Pander
Author: C. Prinsen
Author: L. Purkins
Author: M. Ridd
Author: T. Sach ORCID iD
Author: C.Y. Zhao
Corporate Author: on behalf of the long-term control of eczema working group for the HOME initiative

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×